 | | Cardiovascular Exchange Summit 2011 |
|  | | Atrial Fibrillation Demographics by Age |
|
 | | AF – an epidemic |
|  | | AF Increases Mortality |
|
 | | Hospitalisation Rates Among AF Patients |
|  | | AF treatment - Stroke Prevention & Symptom Management |
|
 | | Control of Ventricular Rate in Atrial Fibrillation |
|  | | Impact of Drug Therapy on Exercise Ventricular Rate in Atrial Fibrillation |
|
 | | Vaughan Williams Classification of Antiarrhythmic Drugs |
|  | | Rhythm control for AF-Duration and Cardioversion |
|
 | | Atrial Fibrillation-Antiarrhythmic Therapy |
|  | | AADs for AF |
|
 | | Dronedarone |
|  | | ESC Guidelines for Paroxysmal AF Management |
|
 | | Dronedarone - NICE Guidance |
|  | | Rate vs Rhythm control-AFFIRM - all-cause mortality |
|
 | | AFFIRM - Prevalence of SR at follow-up |
|  | | Non-pharmacological AF Treatment Options |
|
 | | Outcome After AVN Ablation and Pacing |
|  | | The Pulmonary Vein Potential |
|
 | | Location of Triggering Foci |
|  | | Initiating and Maintaining Atrial Fibrillation |
|
 | | Progression of paroxysmal to persistent AF-HATCH Score |
|  | | AF ablation - randomised trials |
|
 | | AF ablation – heart failure pts |
|  | | AF – Stroke prevention |
|
 | | CHA2DS2VASc Score |
|  | | Efficacy of Warfarin Compared with Control for the Prevention of Ischaemic Stroke |
|
 | | Beyond warfarin… |
|  | | Dabigatran – RE-LY trial |
|
 | | Stroke prevention - Dabigatran |
|  | | Anticoagulation in AF |
|
 | | AF – an evolving epidemic |
|
Deel deze pagina met collega's en vrienden: